Pharmaceutical Painkillers vs CBD

Published: 24 February 2026
Last Updated: 27 July 2026
Last Reviewed: 27 July 2026
Author: Weed Supermarket Editorial Team

Cannabis for Pain: A UK Guide

Chronic pain affects millions of people across the United Kingdom and remains one of the most common reasons for visiting a GP. Prescription medicines such as codeine, tramadol and morphine continue to play an important role in pain management, but growing awareness of their long-term risks has encouraged many people to explore alternative approaches.

One area receiving increasing attention is the use of legal cannabinoids such as CBD (cannabidiol), CBG (cannabigerol) and THCa. While research into cannabis-derived compounds continues to evolve, it’s important to separate evidence from opinion and understand what current UK guidance says.

This guide compares prescription painkillers with legal cannabinoid products, explains the current evidence, and outlines the legal position in the UK.

How Prescription Opioid Painkillers Work

Opioid medicines work by binding to receptors within the brain and spinal cord that regulate the perception of pain.

Common opioid medications include:

Codeine
Tramadol
Morphine
Oxycodone
Fentanyl

These medicines are highly effective for acute pain, post-operative recovery and palliative care. However, they are generally not recommended as long-term treatment for chronic non-cancer pain due to the risks associated with prolonged use.

Potential Risks of Long-Term Opioid Use

Physical dependence.
Tolerance requiring higher doses.
Constipation.
Drowsiness and impaired concentration.
Nausea.
Respiratory depression.
Withdrawal symptoms if stopped abruptly.

Current UK guidance increasingly recommends limiting long-term opioid prescribing where possible and considering non-pharmacological approaches alongside medication.

What Are Legal Cannabinoids?

The cannabis plant naturally contains over one hundred cannabinoids.

The best-known include:

CBD (Cannabidiol) – non-intoxicating and widely researched.
CBG (Cannabigerol) – often referred to as the “parent cannabinoid”.
THCa (Tetrahydrocannabinolic Acid) – the naturally occurring acidic precursor found within raw cannabis plants.
THC (Tetrahydrocannabinol) – the primary intoxicating cannabinoid and a controlled substance within the UK.

Unlike THC, CBD and CBG do not produce intoxication. Interest in these cannabinoids has grown significantly as research explores their interaction with the body’s endocannabinoid system.

Learn more in our guide to the CBD Entourage Effect.

What Does the Current Evidence Say?

Research into cannabinoids for chronic pain continues to develop.

Several systematic reviews have concluded that while some patients report improvements in pain, sleep or overall wellbeing, high-quality evidence remains limited for many chronic pain conditions.

As a result, UK organisations including NICE recommend that treatment decisions should be individualised and guided by appropriately qualified healthcare professionals.

Current evidence does not support replacing prescribed opioid medication with cannabinoid products without medical supervision.

Comparing Prescription Painkillers and Cannabinoids

Consideration	Prescription Opioids	Legal Cannabinoids
Primary purpose	Acute, severe and palliative pain management.	General wellness products and ongoing scientific research.
Dependence risk	Well documented.	CBD and CBG are not considered intoxicating.
Side effects	Can include constipation, drowsiness, nausea and respiratory depression.	May include tiredness, digestive upset or interactions with some medicines.
NHS availability	Commonly prescribed.	Medical cannabis prescriptions remain limited to specific indications.
Evidence for chronic pain	Limited benefit for long-term non-cancer pain.	Research remains ongoing and evidence continues to develop.

Medical Cannabis in the UK

Cannabis-based medicinal products have been available under specialist prescription since 2018.

However, NHS prescribing remains limited to specific medical conditions, including:

Certain rare forms of epilepsy.
Chemotherapy-induced nausea and vomiting.
Spasticity associated with multiple sclerosis.

Chronic pain is not routinely approved for NHS prescribing, although some private specialist clinics may prescribe cannabis-based medicinal products following clinical assessment.

CBD and CBG Products

Many people interested in cannabinoids choose legal CBD or CBG products because they are non-intoxicating and widely available within UK regulations.

Choosing Quality Matters

Not all cannabinoid products are manufactured to the same standards.

When selecting products, look for suppliers who provide:

Independent laboratory testing.
Certificates of Analysis (COAs).
Batch traceability.
Transparent ingredient information.
UK compliance documentation.

Learn more about our testing standards in our UK Compliance & Laboratory Testing guide.

Frequently Asked Questions

Can CBD replace tramadol or morphine?

Current medical evidence does not support replacing prescription opioid medicines with CBD without guidance from a qualified healthcare professional.

Is medical cannabis available on the NHS?

Yes, but only for a small number of specialist indications under very specific circumstances.

Are CBD products legal in the UK?

Yes. Hemp-derived CBD products may be sold legally when they comply with UK regulations relating to THC content and other applicable legislation.

Are prescription opioids addictive?

Long-term opioid use carries recognised risks of tolerance, dependence and withdrawal. Medicines should always be taken exactly as prescribed.

Can CBD interact with medication?

Yes. CBD may interact with certain prescription medicines. Always discuss cannabinoid use with your GP, pharmacist or specialist before introducing new supplements.

Final Thoughts

Managing chronic pain is rarely straightforward, and no single treatment works for everyone. Prescription opioids remain important medicines for many patients, particularly in acute and palliative settings, but their long-term use requires careful monitoring.

Research into cannabinoids such as CBD, CBG and THCa continues to expand, and while interest remains high, more high-quality clinical evidence is needed before definitive conclusions can be drawn regarding chronic pain management.

If you are considering legal cannabinoid products, choose reputable suppliers offering independent laboratory testing and always discuss any changes to your treatment plan with an appropriately qualified healthcare professional.

Compliance Statement

This article is provided for educational purposes only and should not be interpreted as medical advice. Always consult a suitably qualified healthcare professional before starting, stopping or changing any medication or supplement.

Cart

Pharmaceutical Painkillers vs CBD for Pain | UK Guide